Neuromuscular Diseases

Neuromuscular Diseases

Central Laboratory Capabilities

With laboratories in the US, Europe, China and Singapore, Medpace Labs has the global reach and capabilities to conduct neuromuscular disease studies in concert with our full-service CRO or as a standalone service. Key highlights include:

  • Extensive menu of biomarkers that use state of the art techniques, and provide results that enable patient stratification and improve prediction of drug efficacy and safety.
  • Scientific engagement throughout the development lifecycle from our global team of experts who have extensive central laboratory operations experience
  • Over 19,000 square feet of biorepository services located at our four global central laboratory locations
  • In-house logistical team that manages all shipments of collection kit supplies and laboratory manuals to clinical sites
  • Seamless integration with a robust network of laboratory partners, some which specialize in CNS testing such as CSF biomarkers and genotyping.

Core Imaging Expertise for Neuromuscular Disease Studies

High-quality image acquisition and interpretation is crucial for the success of trials relying on neuroimaging for patient selection or as a primary endpoint. Medpace provides centralized neuroimaging expertise, led by radiologists and neurologists with decades of clinical and trial experience.

Medpace Imaging Core Lab provides an end-to-end suite of imaging services to enhance and expedite biopharmaceutical and imaging contrast agent development, including a broad spectrum of imaging biomarkers for DMD trials. Capabilities include:

  • MR Spectroscopy
  • T2 Mapping
  • Muscle Fat Fraction
  • PDFF Complex
  • MR Elastography